Enumeration of CD4 and CD8 T-cells in HIV infection in Zimbabwe using a manual immunocytochemical method by Gomo, E. et al.
Vol. 47, No. 3 CONTENTS
/
ORIGINAL ARTICLES
Determinants of reproductive tract infections 
among asymptomatic women in Harare, Zimbabwe 
Enumeration of CD4 and CD8 T-ceils in HIV 
infection in Zimbabwe using a manual
immunocytochemical method...............................
Post operative pain therapy: a survey of 
prescribing patterns and adequacy of analgesia
in Ibadan, Nigeria.................................................
Prediction of peak expiratory flow rates in 
stunted children.....................................................
CASE REPORT
Superficial brachial artery terminating as radial 
and superficial ulnar arteries: a case report..........
LETTERS TO THE EDITOR
Topographical relations of die vertebral arteries 
in the human neck: an anatomical study ............
OBITUARY
Dr Evelyn Davey ..................................................
ERRATUM
Antibiotic sensitivity and plasmid profiles of 
pseudomonas aentgint >sa
X  NOTES AND NEWS
Instructions to Authors ...
EM Mbizvo, SE Msuya, B Stray-Pcdersen 
J Sundby, ZM Chirenje, A Hussain
E Gomo, P Ndhlovu, BJ Vcnnci vaM, 
N Nyazema, H Friis
AF Faponle, OA Soyannwo, IO Ajayi .................70
Y Zverev............................................................. ..74
PVV Prasada Rao, SC Chaudhary......
G Mawera, B Hillen
................ 78
...................81
H Goodwin, D Shennan........................................ 83
...84
Central A frican Jou rna l o f  M edicine . 4
Enumeration of CD4 and CD8 T-cells in HIV infection in 
Zimbabwe using a manual immunocytochemical method
*E GOM O,* *P NDHLOVU, ***BJ VENNERVALD, #N NYAZEMA, "H FRIIS
Abstract
Objectives: To enumerate CD4 and CD8 T-cells using the simple and cheap immuno-alkaline phosphatase 
(IA) method and to compare it with flow cytometry (FC); and to study the effects of duration of sample storage 
on the IA method results.
Design: Method comparison study.
Setting: Blair Research Laboratory, Harare, Zimbabwe.
Subjects: 41 HIV positive and 11 HIV negative men and women from Harare participating in HIV studies at 
Blair Research Laboratory, Zimbabwe
Main Outcome Measures: CD4 and CD8 T-cell counts by FC and the IA method.
Results: The IA method and FC were highly correlated for CD4 counts (Spearman rs=0.91), CD4 percentage 
(rs=0.84), CD8 count (r =0.83), CD8 percentage (^=0.96) and CD4/CD8 ratio (rs =0.89). However, CD4 cell 
counts and percentage measured by the IA method were (mean difference ±SE) 133 ± 24 cells/mL and 6.7 ±
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1.1% higher than those measured by the FC method (p<0.0001) respectively. CD8 counts and percentages by 
the IA method were lower than those by the FC method (p<0.01). Accordingly, the IA method gave a higher 
CD4/CD8 ratio (p<0.01). IA method CD4 counts <300/mLbest predicted FC CD4 counts <200/mL while IA 
CD4% <25 best predicted FCCD4% <14%. IAmethodCD4/CD8 ratio <0.8bestpredictedFCCD4/CD8 ratio 
<0.5. Smears stored for up to 18 months gave results similar to fresh smears.
Conclusion: The LA method correlates well with but gives CD4 counts and percentages that are higher than 
those determined by FC. On the contrary, the IA method gives CD8 counts and percentage that are lower than 
FC values. The method is a cheap and reliable alternative to FC and allows storage of samples for extended 
periods before analysis, making it an appropriate technology for resource^ppvor countries.
Introduction
The clinical manifestations of HIV infection are mostly 
dependent on the level of CD4 cells.1’2 Where viral load 
assays are not available, a rise in the CD4 count is an 
acceptable indication of treatment efficacy. In addition, 
CD4 cell levels are very useful when deciding on the time 
to start or stop prophylaxis against certain opportunistic 
infections.1,2
The standard method for quantifying T-cell subsets is 
flow cytometry (FC). However, the method requires 
expensive instruments, maintenance and highly trained 
technologists. Thus this method of T-cell subset 
determination cannot be readily available for routine use in 
developing countries. Simple, reliable and inexpensive 
alternative methods are needed in these countries where 
HIV infection and AIDS are highly prevalent, and where 
financial and technical resources are limited. Furthermore, 
it would be useful if such methods allowed analysis of 
samples after relatively long periods of storage.
Several alternative technologies for CD4 and CD8 T-cell 
phenotypinghave been developed and evaluated.3'11 Among 
these methods is the immuno-alkaline phosphatase (IA) 
method.4’12 This method is based on the principle that anti- 
CD4 or CD8 monoclonal antibodies react with CD4 or 
CD8 molecules on cells in a haematological smear.12 This 
antigen-antibody reaction is then visualised by addition of 
an enzyme-labelled antibody raised against the anti-OD4 
or CD8. The IA method has been shown to be reproducible 
and reliable in four African countries.4 Furthermore, the 
method has been shown to be cheaper than FC and to allow 
examination of smears after long periods of storage.3
In Zimbabwe, although management of HIV infection is 
mostly palliative, the use of anti-retroviral drugs in treatment 
of HIV infection is increasing. This has resulted in an 
increased requirement for CD4 counts in clinical practice. 
Thus the need for cheaper methods of T-cell subset 
determination cannot be over emphasized. We, therefore, 
validated the IA method by comparing it with standard FC 
using the FACSCount system for potential use in research 
and clinical practice. The effect of storage of samples on 
the performance of the IA method was also evaluated.
Materials and Methods
Study Population.
The study population were men and women who knew 
their HIV serostatus through participating in HIV studies
at Blair Research Laboratory in Harare, Zimbabwe. 
Information about the study was provided and volunteers 
enrolled. Counselling was provided as part of the HIV 
studies in which the subjects were participating.
Blood Collection and Processing.
Venous blood was collected in two EDTA tubes and in 
one plain tube. The anti-coagulated blood was used to 
prepare 6 haematological smears. The smears were air 
dried, wrapped in aluminium foil and stored at -20“C until 
immunocytochemical analysis for CD4 and CD8 cells. 
The remaining anti-coagulated blood was used for total 
and differential white blood cell counts (Coulter MaxM, 
Denmark), and for CD4 and CD8 T-cell enumeration by 
FC. Serum obtained from the other tubes was tested for 
HIV antibodies using commercial enzyme-linked 
immunosorbent assay kits following manufacturer’s 
instructions (Genelavia Mixt®, Sanofi, France and 
Recombigen, Trinity Biotech, Ireland).
Flow Cytometry.
The FACSCount system (Becton Dickenson, NJ, USA) 
was used for automated CD4 and CD8 counts within 24 
hours of blood collection. Anti-coagulated blood was 
added to reagent tubes containing fluorochrome conjugated 
monoclonal antibodies to CD3 and CD4 or CD8 (Becton 
Dickenson, NJ, USA) and incubated for two hours at room 
temperature. Fixative was added and samples incubated at 
room temperature for a minimum of two hours before 
enumeration. In the enumeration process, a known number 
of reference beads contained in each reagent tube functions 
as a fluorescence and quantitation standard for calculating 
the absolute CD4+, CD8+ and CD3+ T cells. The 
FACScount system software collects up to 30 000 events 
per sample so that the precision of the measurements is not 
limited by statistical samplingvariation. The FACS Count’s 
usable range for CD4 T cells is 50 to 2 000 cells/pL, for 
CD8 100 to 2 000 cells/pL and for CD3 100 to 3 500 cells/ 
pL. Manufacturer’s instructions on quality control 
procedures were followed. CD4 and CD8 percentages 
were the proportion of total lymphocytes that were CD4+ 
or CD8+ expressed as a percentage. The total lymphocyte 
count was derived from the Coulter counts. 
Immuno-alkaline Phosphatase Method.
Stored smears were processed within one month of 
sample collection. The immuno-alkaline phosphatase 
method was used for CD4 and CD8 phenotyping as 
described in the World Health Organisation (WHO) manual 
for developing countries13 and by Lisse et al (1997).4
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Briefly, frozen blood smears were left to reach room 
temperature before they were fixed in acetone:methanol 
for 30 seconds. The smears were washed in 0.05M Tris 
buffered saline (TBS) pH 7.6 (Saarchem Pvt Ltd, South 
Africa) and incubated with 2% bovine serum albumin 
(BSA) in TBS for 10 minutes. Mouse anti-human CD4 or 
CD8 monoclonal antibody (Dako, Denmark) was added 
and the smears incubated in a moist chamber overnight at 
4°C. After washing in TBS, biotinylated rabbit anti-mouse 
(Dako, Denmark) was added followed by avidin-biotin- 
alkaline phosphatase complex (Dako, Denmark) and Fast 
Red substrate (Dako, Denmark). The substrate stains the 
CD4+ or CD8+ cells red. Once the CD4+ or CD8* cells were 
clearly visible under the microscope, smears were counter- 
stained with alcohol free Mayer’s hematoxylin stain (Sigma, 
Germany) and mounted with glycerol (Dako, Denmark). 
Using a light microscope (x40 objective) the number of 
CD4+ or CD8+cells per 200 lymphocytes were counted and 
the results reported as number of CD4+ or CD8+ cells per 
200 lymphocytes. The absolute CD4 count was calculated 
as follows: CD4+/200 x WBC x %lymphocyte. The 
lymphocyte percentage and WBC values were derived 
from Coulter counts. Smears with known CD4 counts and 
percentage were included in all batches of smears stained 
to ensure quality of the immunostaining and enumeration 
procedures.
Effect of Duration of Storage.
In order to assess the effect of storage on detection of the 
CD4 T cell marker, a batch of smears from two HIV 
positive and two HIV negative individuals with known 
CD4 percent was stored. Once every six months, one smear 
from each of the individuals was retrieved and included in 
the staining procedures. The CD4 percentages were then 
compared to determine the effect of storage on the 
immunophenotyping process using the IA method.
Data Analysis.
The Mann-Whitney U-test was employed to compare 
between groups. The Wilcoxon Signed Rank test was used 
for paired analysis of the two methods. Spearman’s rank 
correlation (r j  assessed the degree of association between 
the results of the two methods. Means and standard deviation 
of differences between the two methods were used to 
determine the agreement of the methods.14 The 95% limits 
of agreement were defined as mean difference ± 1.96 SD. 
Various cut-offs of IA CD4 counts and percentage were 
used to evaluate the sensitivity and specificity of the IA 
method to identify low FC CD4 counts (< 200/mL) or 
percentage (<14%).
Results
Paired FC and IA CD4 counts were available from 52 
individuals (median age 26.5, range 18 to 42years). Thirty 
five (67.3%) were females, 29 of whom were HIV positive, 
while 12 (70.6%) of the 17 males were HIV positive. Males 
were older than females (median age, 35.0 versus 25.2 
years, pcO.0001). Overall, based on FC results, CD4
counts ranged from 17 to 1 981 cells/pL with a median of 
408 cells/pL. Median CD8 count was 899, range 157 to 
1 924 cells/pL while CD4/CD8 ratio ranged from 0.05 to 
2.94 with a median 0.47. IA method and FC results obtained 
showed that CD4 counts, percentages and CD4/CD8 were 
lower and CD8 counts and percentage were higher in HIV 
positive than in negative individuals (p<0.01). 
Correlation Between FC and IA CD4 and CD8 T-cell 
Measurements.
Figure I shows scatter plots of IA against FC values for 
CD4 and CD8 counts and percentages and for CD4/CD8 
ratio, with the line of equality describing the relationship. 
The IA CD4 counts were highly correlated with FACS 
CD4 counts (Spearman rs=0.91; p<0.0001). Similarly IA 
method CD4 percent (r =0.86), CD8 counts (^=0.83), 
CD8% (^=0.96) and CD4/CD8 ratio (r=0.89) were highly 
correlated with FACS results (pcO.0001 for all).
Table I: Mean and standard deviations (SD) oflA and FC 
CD4 and CD8 counts, percentage and ration, with mean 
differences ( SD) between the methods.
Methods
IA FC Difference*
CD4 (n=52)
C e lls /n L 688 (565 555 (473) 133 (170)
P ercen t 33.2(17.0) 26.5(15.9) 6.7 (8.0)
CD8 (n=27)
C e lls /n L
P ercen t
814(341) 
40.1 (14.3)
890 (384) 
45.2 (18^ 3)
-76(183) 
-5.0 (5.8)
CD4/CD8 ration (n=27) 1.10(0.95) 0.85 (0.75 0.25 (0.37)
*Difference =IA -FC.
Agreement of Methods.
Table I shows the mean (SD) of CD4 and CD8 counts, 
percentage and CD4/CD8 ratio, and the mean differences 
(SD) between the IA and FC methods. IA CD4 counts and 
percentages were significantly higher than FC values (688 
versus 555 cells/mL and 33.2 vs 26.5%; Wilcoxon Signed 
Rank test, p<0.0001 respectively). Thus the IA method 
gave CD4 counts that were higher than FC counts by (mean 
difference ±SE) 133 ± 24 cells/mL; p<0.001) and the 95% 
limits of agreement of the methods were (mean difference 
+SD) 133 ± 170 or -198 to 464 cells/mL. There was no 
difference in agreement between the two methods at FC 
CD4 counts below and above 500/mL (mean difference 
+SD, 105 ± 118 vs 178 + 226 cells/mL; p=0.13) (Figure I). 
The mean difference ±SE between the IA and FC method 
CD4% was 6.7 ± 1.1. The 95 % limits of agreement between 
the two methods were 67 ± 8.0% or -9.0% to 22.4%. The 
agreement was also similar at FC CD4% below and above 
25% (6.9 ± 6.6 vs 6.4 ± 9.5; P=0.85) (Figure II).
IA CD8 counts and percentages were lower than FC 
values (814 vs 890 cells/mL,p=Q.029 and 40.1 vs 45.2%, 
p<0.001 respectively). The mean difference ±SE were -76 
+ 36 cells/mL and -5.0 + 1.1% respectively. The limits of 
agreement for CD8 counts and percentage were -76 + 183
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Figure I: Scatter plots ofCD4 and CD8 counts and %, and CD4/CD8 ratio by the IA against FC method, with line-of 
equality.
Figure II: Plots o f differences in CD4 counts and % between the IA and FC methods against the average values for the two 
methods.
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or -435 to 283 cells/pL and -5.0 ± 5.8 or -16.5 to 6.3% 
respectively. Because of the higher CD4 and lower CD8 
percentages, the IA method gave CD4/CD8 ratio that was 
(mean difference ±SE) 0.25 ± 0.07 higher than that by the 
FC method (p s  0.001) (Table I). The 95% limits of 
agreement were 0.25 ± 0.37 or -0.48 to 0.98.
Sensitivity and Specificity of the IA Method.
Sensitivity and specificity of the IA method to identify 
low CD4 counts (<200/mL by FC method) was evaluated 
at IA CD4 counts <200, <250 and <300 cells/mL. Similarly,
sensitivity and specificity of IA CD4% <14, <16, <20 and 
25 to detect FC CD4% <14 are shown in Table II. The 
ability of the IA method to correctly identify FC counts 
<200 cells/p,L was highest with an IA method cut-off of 
300 cells/pL, and lowest when a cut-off of <200 cells/p,L. 
An IA CD4 percent cut-off of <14% could only correctly 
identify 18.8% of FC values <14% whereas IA CD4% <25 
best predicted FC CD4 <14%. On the other hand, an IA 
CD4/CD8 ratio <0.8 had over 90% sensitivity and 
specificity in identifying FC CD4/CD8 ratio <0.5.
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Table II: Sensitivity and specificity ofthe lA method in 
classifying low (<200 cells/pL) FACS count CD4 counts 
and percent, and CD4/CD8 ratio.
IA CD4 level Sensitivity* Specificity**
CD4 count (cells/uL)
<200 50.0% (7/14) 100% (38/38)
<250 78.6% (11/14) 97.3% (37/38)
<300 85.7% (12/14) 94.7% (36/38)
CD4%
<14 18.8% (3/16) 100% (36/36)
<16 43.8% (7/16) 97.2% (35/36)
<20 62.5% 10/16) 91.7% (33/36)
<25 100% (16/16) 75.0% (27/36)
CD4/CD8 ratio
<0.5 57.1% (8/14) 91.7% (11/12)
<0.8 92.9% (13/14) 91.7(11/12)
<1.0 100% (14/14) 66.7%(8/12)
*  The figures in parentheses are the proportion of FACScount CD4 values 
<200/uL correctly identified by the appropriate IA cut-off.
* *  The figures in parentheses are the proportions of FACScount CD4 values 
3200/uL correctly identified by the appropriate IA cut off.
Observer Variation.
The positive methodologic control used showed that 
precision of the IA method was 5.4%. Intra- and inter­
observer variation of the IA enumeration of CD4 cells was 
evaluated by double reading by one and two observers, 
respectively. The coefficient (SD) of intra-observer 
variation was 6.3 (8.3)% and that of inter-observer variation 
was 8.9 (5.7)%. Intra-observer variation was lower when 
CD4 counts were <200/pL compared to >200/pL (2.1% 
versus 6.8%, Mann-Whitney U-test;p=0.001) but inter­
observer variation was similar for CD4 counts <200/pL 
compared to >200/pL (10.8% versus 8.5%; p=0.09). 
Effect of Storage on CD4 Count.
To evaluate effect of storage on antigenicity of CD4, 
smears from four subjects were stained and enumerated 
within one month and after six, 12 and 18 months of 
storage. The mean (SD) CD4% at these time points was 
28.1 (13.7), 26.1 (16.8), 30.9 (11.6) and 23.4 (11.6) 
respectively. There was no difference in CD4% between 
the specified time points (Kruskal Wallis,p=0.60) indicating 
no significant change in CD4%‘. However, counts at 18 
months tended to be lower than at earlier times.
Discussion
The present study has shown that the IA method CD4 and 
CD8 counts, percentage and ratio correlate well with FC 
values. However, the two methods are not interchangeable 
because the IA method gives consistently higher CD4 
counts and percentages as has been observed by others.3,4 
There is no obvious explanation for the higher counts but 
this has been attributed to a qualified identification of 
lymphocytes by the manual method, whereas FC could 
miss CD4 T-cells weakly stained by the fluorochrome.3,15 
Alternatively, in the IA method, CD4 positive monocytes 
could be mistaken for CD4 T-cells.
That CD8 counts and percentage by the IA method were 
lower than the FC CD8 T-cell values is in agreement with 
a recent study comparing the results of the IA method 
performed in four countries.4 However, the same authors 
previously reported higher CD8 T-cell percentage by the 
IA compared to FC.3 This variation in CDS T-cell values 
may be partially dependent on the monoclonal antibodies 
used and the heterogeneity of the CD8 molecules.4 
Nonetheless, because of the higher CD4 and lower CD8 T- 
cell percentage, we found that the IA method consistently 
gave higher CD4/CD8 ratios than those derived from FC. 
The wide limits of agreement suggest wide variation in 
individual measurements by the IA method and would 
likely be much lower with larger sample sizes. Indeed a 
total of only 200 lymphocytes were counted in the IA 
method. In contrast, the FACScount systems records up to 
30 000 events per sample in the counting process such that 
the precision of the measurement is not limited by statistical 
sampling variation. It is, therefore, important that the IA 
method be evaluated further with larger sample sizes that 
will also enable conversion factors to be determined to 
allow estimation of FC equivalents where this is deemed 
necessary.
Flow cytometry CD4 T-cell counts below 200/mL are 
associated with the immunosuppression characteristic of 
AIDS in HIV infected individuals.1,2 Thus monitoring of 
CD4 cell counts guides management of HIV infected 
patients. Since the IA method gives higher CD4 values, it 
is essential that the appropriate cut-offs be determined to 
enable clinical application of the IA method results. In the 
present study, the IA CD4 T-cell level of <300/p.L gave the 
highest sensitivity in the identification of FC CD4 counts 
<200/pL and therefore in classifying AIDS patients. This 
is in accordance with the observed bias of 133 cells/pL 
between the two methods. The sensitivity of 86% achieved 
by the IA CD4 count cut-off of <300/pL is similar to that 
of Lisse et al. at 81% 4. It has been suggested that CD4% 
is amore reliableparameter than absolute counts in assessing 
immune status,16 and a FC CD4 percentage below 14% 
(low CD4%) roughly corresponds to an absolute count of 
<200 CD4 cells/pL. In the present study maximum 
sensitivity of the IA method was achieved by a cut-off of 
<25%. Furthermore, CD4% of <25% was associated with 
IA absolute counts <300/pL and FC values <200/pL (data 
not shown). Our data suggests that the IA method cut-offs 
have adequate diagnostic sensitivity and specificity for 
classification of HIV disease in our setting.
T-cell phenotyping is subject to significant technical and 
physiologic variability,17'20 and correct interpretation of 
results depends on the precision and reproducibility of the 
method used. With the IA method, variation in 
measurements could arise from differences in affinity of 
monoclonal antibodies in different lots or by different 
manufacturers, or due to observer error. Alternatively, 
results could also depend on the method used to evaluate 
the total lymphocyte and white blood cell count. Manually 
determined total lymphocyte counts have been shown to be
higher than those from an automated haematology analyser.3 
We assessed intra- and inter-observer variation and found 
them to be within acceptable ranges compared to other 
alternative CD4 technologies.6’9 This suggests that observer 
error is unlikely to hamper use of the IA method, provided 
the microscopists are well trained. The method has been 
shown to be reproducible in different settings in Africa and 
Europe.3,4 However, even using FC there is considerable 
variation in results due to differences in instruments, 
reagents and processing of specimens.15
We have also shown that blood smears can be kept at 
-20°C for up to 18 months and still give results that are 
similar to fresh smears. However, this was assessed on 
only four subjects and may need to be verified with larger 
sample sizes.
The use of CD4 counts is increasing in developing 
countries as HIV infected individuals become more aware 
of the importance of the parameter in prognosis, and 
clinicians battle to improve the management of ever 
increasing numbers of AIDS patients in the absence of 
anti-retroviral drags. The present study has shown that the 
IA method could be relied upon as an alternative to flow 
cytometry and could offer expanded availability of CD4 
evaluation to individuals with HIV infection in Zimbabwe. 
We have determined CD4 count and percentage cut-offs 
that are applicable with the IA method thereby allowing 
application of the method in classification of HIV disease 
and other immuno-deficient conditions in the Zimbabwean 
setting. The cost of the IA method is six-fold cheaper than 
FC kits based on costs of reagents only (data not shown). 
Clearly, if the costs of equipment repair and maintenance 
were added, then the IA method would be many times 
cheaper than FC.
In conclusion, the IA method does not require expensive 
instruments or laboratories and enables samples to be 
analysed long periods after collection. The method is, 
therefore, appropriate for use in developing countries with 
poor resources. However, the results of the IA method 
should be interpreted in cognisance of the fact that the 
method gives CD4 counts that are about 100 cells/gL 
higher than those of flow cytometry and that the accuracy 
of the method is heavily dependent on the microscopists. 
Hence the need for well trained microscopists cannot be 
over-emphasized.
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